0R44
vs
O
OMX Stockholm 30
0R44
Over the past 12 months, 0R44 has underperformed OMX Stockholm 30, delivering a return of -18% compared to the OMX Stockholm 30's +33% growth.
Stocks Performance
0R44 vs OMX Stockholm 30
Performance Gap
0R44 vs OMX Stockholm 30
Performance By Year
0R44 vs OMX Stockholm 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
C Rad AB
Glance View
C-RAD AB engages in the development of innovative solutions for use in advanced radiation therapy. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2007-07-23. The company offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The firm operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.
